These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8338920)

  • 1. A prospective study on treatment of hypercholesterolemia with lovastatin in renal transplant patients receiving cyclosporine.
    Cheung AK; DeVault GA; Gregory MC
    J Am Soc Nephrol; 1993 Jun; 3(12):1884-91. PubMed ID: 8338920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lovastatin therapy for hypercholesterolemia in cardiac transplant recipients.
    Kuo PC; Kirshenbaum JM; Gordon J; Laffel G; Young P; DiSesa VJ; Mudge GH; Vaughan DE
    Am J Cardiol; 1989 Sep; 64(10):631-5. PubMed ID: 2675584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of hypolipidemia treatment on the function of kidney transplanted from cadavers].
    Paczek L; Bill M; Wyzgał J; Gaciong Z; Gradowska L; Juskowa J; Durlik M; Lao M
    Pol Arch Med Wewn; 1997 Feb; 97(2):144-56. PubMed ID: 9312763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of fluvastatin for safely lowering atherogenic lipids in renal transplant patients receiving cyclosporine.
    Holdaas H; Hartmann A; Stenstrøm J; Dahl KJ; Borge M; Pfister P
    Am J Cardiol; 1995 Jul; 76(2):102A-106A. PubMed ID: 7604781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lovastatin treatment of hypercholesterolemia in renal transplant recipients.
    Kasiske BL; Tortorice KL; Heim-Duthoy KL; Goryance JM; Rao KV
    Transplantation; 1990 Jan; 49(1):95-100. PubMed ID: 2105548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin E in kidney transplantation: effect of treatment with simvastatin in hypercholesterolemia.
    Cantarell C; Bonal J; Sierra C; Pastor C; Lauzurica R; Capdevila L
    Transplant Proc; 1995 Aug; 27(4):2222-3. PubMed ID: 7652781
    [No Abstract]   [Full Text] [Related]  

  • 7. Low-dose simvastatin is a well-tolerated and efficacious cholesterol-lowering agent in ciclosporin-treated kidney transplant recipients: double-blind, randomized, placebo-controlled study in 40 patients.
    Arnadottir M; Eriksson LO; Germershausen JI; Thysell H
    Nephron; 1994; 68(1):57-62. PubMed ID: 7991041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of lovastatin and probucol on lipoprotein fractions in patients with hypercholesterolemia. A Brazilian multicenter study].
    Forti N; Ramires JA
    Arq Bras Cardiol; 1991 Sep; 57(3):253-61. PubMed ID: 1824203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia.
    Bradford RH; Shear CL; Chremos AN; Dujovne C; Downton M; Franklin FA; Gould AL; Hesney M; Higgins J; Hurley DP
    Arch Intern Med; 1991 Jan; 151(1):43-9. PubMed ID: 1985608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of fluvastatin on hyperlipidemia after renal transplantation: influence of steroid therapy.
    Austen JL; Shifrin FA; Bartucci MR; Knauss TC; Schulak JA; Hricik DE
    Ann Pharmacother; 1996 Dec; 30(12):1386-9. PubMed ID: 8968448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preliminary report of the safety and efficacy of fluvastatin for hypercholesterolemia in renal transplant patients receiving cyclosporine.
    Goldberg RB; Roth D
    Am J Cardiol; 1995 Jul; 76(2):107A-109A. PubMed ID: 7604782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A crossover comparison of the efficacy and safety of lovastatin and gemfibrozil in the treatment of hyperlipidemic organ transplant recipients.
    Hanes DS; Nicholson PG; Raval DD; Hooper FL; Behrens MT; Weir MR
    Am J Ther; 1997; 4(2-3):85-91. PubMed ID: 10423597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia.
    Kerzner B; Corbelli J; Sharp S; Lipka LJ; Melani L; LeBeaut A; Suresh R; Mukhopadhyay P; Veltri EP;
    Am J Cardiol; 2003 Feb; 91(4):418-24. PubMed ID: 12586255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhabdomyolysis and renal injury with lovastatin use. Report of two cases in cardiac transplant recipients.
    Corpier CL; Jones PH; Suki WN; Lederer ED; Quinones MA; Schmidt SW; Young JB
    JAMA; 1988 Jul; 260(2):239-41. PubMed ID: 3290520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy and pharmacokinetics of HMG-CoA reductase inhibitors in heart transplant patients treated with cyclosporin A.
    Regazzi MB; Iacona I; Campana C; Gavazzi A; Viganò M; Perani G
    Transplant Proc; 1994 Oct; 26(5):2644-5. PubMed ID: 7940825
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of pravastatin and lovastatin in renal transplant patients receiving cyclosporine.
    Kliem V; Wanner C; Eisenhauer T; Olbricht CJ; Doll R; Boddaert M; O'Grady P; Krekler M; Mangold B; Christians U
    Transplant Proc; 1996 Dec; 28(6):3126-8. PubMed ID: 8962211
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative efficacy study of atorvastatin vs simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia.
    Gentile S; Turco S; Guarino G; Sasso CF; Amodio M; Magliano P; Salvatore T; Corigliano G; Agrusta M; De Simone G; Gaeta I; Oliviero B; Torella R
    Diabetes Obes Metab; 2000 Dec; 2(6):355-62. PubMed ID: 11225965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of pravastatin in heart-transplant patients taking cyclosporin A.
    Park JW; Siekmeier R; Merz M; Krell B; Harder S; März W; Seidel D; Schüler S; Gross W
    Int J Clin Pharmacol Ther; 2002 Oct; 40(10):439-50. PubMed ID: 12395976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nicotinic acid and lovastatin in renal transplant patients: a prospective, randomized, open-labeled crossover trial.
    Lal SM; Hewett JE; Petroski GF; Van Stone JC; Ross G
    Am J Kidney Dis; 1995 Apr; 25(4):616-22. PubMed ID: 7702060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose lovastatin safely lowers cholesterol after cardiac transplantation.
    Kobashigawa JA; Murphy FL; Stevenson LW; Moriguchi JD; Kawata N; Kamjoo P; Brownfield E; Wilmarth J; Leonard L; Chuck C
    Circulation; 1990 Nov; 82(5 Suppl):IV281-3. PubMed ID: 2225417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.